Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 200.14 -2.05 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.19 | 52 Week High | $333.65 | |||
| Open | $202.75 | 52 Week Low | $223.02 | |||
| Day High | $204.47 | P/E | 25.63 | |||
| Day Low | $199.83 | EPS | $7.81 | |||
| Volume | 762,577 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 46.98 +0.78 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.20 | 52 Week High | $26.84 | |||
| Open | $46.56 | 52 Week Low | $9.51 | |||
| Day High | $48.08 | P/E | N/A | |||
| Day Low | $45.84 | EPS | $-2.62 | |||
| Volume | 523,013 | |||||
